Loading clinical trials...
Loading clinical trials...
A Non-interventional, Multi-center, Retrospective Observational Study to Investigate the Effectiveness and Safety of Olostar Tab in Patients With Essential Hypertension and Dyslipidemia (ROSE Study)
Conditions
Interventions
Other: Not applicable-observational study
Locations
1
South Korea
Dongguk Ilsan University Hospital
Ilsan, South Korea
Start Date
August 1, 2016
Primary Completion Date
June 1, 2018
Completion Date
June 1, 2018
Last Updated
January 4, 2017
NCT02417740
NCT07073820
NCT07480265
NCT06876233
NCT06062394
NCT06899815
Lead Sponsor
Daewoong Pharmaceutical Co. LTD.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions